• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗性 siRNA 的递药系统和局部给药途径。

Delivery systems and local administration routes for therapeutic siRNA.

机构信息

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Av. do Café, s/n, 14040-903, Ribeirão Preto, SP, Brazil.

出版信息

Pharm Res. 2013 Apr;30(4):915-31. doi: 10.1007/s11095-013-0971-1. Epub 2013 Jan 24.

DOI:10.1007/s11095-013-0971-1
PMID:23344907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7088712/
Abstract

With the increasing number of studies proposing new and optimal delivery strategies for the efficacious silencing of gene-related diseases by the local administration of siRNAs, the present review aims to provide a broad overview of the most important and latest developments of non-viral siRNA delivery systems for local administration. Moreover, the main disease targets for the local delivery of siRNA to specific tissues or organs, including the skin, the lung, the eye, the nervous system, the digestive system and the vagina, were explored.

摘要

随着越来越多的研究提出新的和最佳的递送策略,通过局部给予 siRNA 来有效沉默与基因相关的疾病,本综述旨在广泛概述用于局部给予的非病毒 siRNA 递送系统的最重要和最新进展。此外,还探讨了局部给予 siRNA 到特定组织或器官的主要疾病靶标,包括皮肤、肺、眼睛、神经系统、消化系统和阴道。

相似文献

1
Delivery systems and local administration routes for therapeutic siRNA.治疗性 siRNA 的递药系统和局部给药途径。
Pharm Res. 2013 Apr;30(4):915-31. doi: 10.1007/s11095-013-0971-1. Epub 2013 Jan 24.
2
Nonviral in vivo delivery of therapeutic small interfering RNAs.治疗性小干扰RNA的非病毒体内递送
Curr Opin Mol Ther. 2007 Aug;9(4):345-52.
3
Functional nanostructures for effective delivery of small interfering RNA therapeutics.用于有效递送小干扰RNA疗法的功能性纳米结构。
Theranostics. 2014 Sep 19;4(12):1211-32. doi: 10.7150/thno.8491. eCollection 2014.
4
A review of the current status of siRNA nanomedicines in the treatment of cancer.一种用于癌症治疗的 siRNA 纳米药物的现状综述。
Biomaterials. 2013 Sep;34(27):6429-43. doi: 10.1016/j.biomaterials.2013.04.060. Epub 2013 May 30.
5
Non-viral siRNA delivery to the lung.非病毒小干扰RNA向肺部的递送。
Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):124-33. doi: 10.1016/j.addr.2007.03.003. Epub 2007 Mar 15.
6
siRNA delivery: from basics to therapeutic applications.siRNA 递呈:从基础到治疗应用。
Front Biosci (Landmark Ed). 2013 Jan 1;18(1):58-79. doi: 10.2741/4087.
7
siRNA delivery systems for cancer treatment.用于癌症治疗的小干扰RNA递送系统。
Adv Drug Deliv Rev. 2009 Aug 10;61(10):850-62. doi: 10.1016/j.addr.2009.04.018. Epub 2009 May 5.
8
Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy.非病毒载体介导的siRNA肿瘤靶向递送:安全有效的癌症治疗方法
Expert Opin Drug Deliv. 2008 Dec;5(12):1301-11. doi: 10.1517/17425240802568505.
9
Targeted delivery systems of small interfering RNA by systemic administration.通过全身给药实现小干扰RNA的靶向递送系统
Drug Metab Pharmacokinet. 2007 Jun;22(3):142-51. doi: 10.2133/dmpk.22.142.
10
Therapeutic face of RNAi: in vivo challenges.RNA干扰的治疗前景:体内挑战
Expert Opin Biol Ther. 2015 Feb;15(2):269-85. doi: 10.1517/14712598.2015.983070. Epub 2014 Nov 15.

引用本文的文献

1
Molecular targets and therapies associated with poor prognosis of triple‑negative breast cancer (Review).与三阴性乳腺癌预后不良相关的分子靶点与治疗(综述)
Int J Oncol. 2025 Jun;66(6). doi: 10.3892/ijo.2025.5758. Epub 2025 May 30.
2
Recent Update on siRNA Therapeutics.小干扰RNA疗法的最新进展
Int J Mol Sci. 2025 Apr 8;26(8):3456. doi: 10.3390/ijms26083456.
3
Advances in locally administered nucleic acid therapeutics.局部给药核酸疗法的进展。

本文引用的文献

1
Liquid crystalline phase nanodispersions enable skin delivery of siRNA.液晶相纳米分散体可实现 siRNA 的经皮递送。
Eur J Pharm Biopharm. 2013 Jan;83(1):16-24. doi: 10.1016/j.ejpb.2012.08.011. Epub 2012 Sep 23.
2
Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer.利用肽增强剂将 siRNA 和其他大分子递送入皮肤和细胞中。
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15816-21. doi: 10.1073/pnas.1016152108. Epub 2011 Sep 8.
3
Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma.
Bioact Mater. 2025 Mar 10;49:218-254. doi: 10.1016/j.bioactmat.2025.02.043. eCollection 2025 Jul.
4
Fabrication of 3D Printed, Core-and-Shell Implants as Controlled Release Systems for Local siRNA Delivery.3D打印核壳植入物的制造,作为用于局部siRNA递送的控释系统。
Adv Healthc Mater. 2023 Dec;12(31):e2301643. doi: 10.1002/adhm.202301643. Epub 2023 Sep 25.
5
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy.乳腺癌:微小RNA监测化疗耐药性及全身治疗
Front Oncol. 2023 Jun 16;13:1155254. doi: 10.3389/fonc.2023.1155254. eCollection 2023.
6
Impaired Blastocyst Formation in -Knockdown Mouse Embryos.- 基因敲除小鼠胚胎囊胚形成障碍。
Int J Mol Sci. 2023 Jan 10;24(2):1385. doi: 10.3390/ijms24021385.
7
Biomedicine Innovations and Its Nanohydrogel Classifications.生物医学创新及其纳米水凝胶分类
Pharmaceutics. 2022 Dec 18;14(12):2839. doi: 10.3390/pharmaceutics14122839.
8
Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery.用于肺部递送的 siRNA 多聚体的肺表面活性剂包被优化
Pharm Res. 2024 Jan;41(1):77-91. doi: 10.1007/s11095-022-03443-3. Epub 2022 Nov 29.
9
Effect of the array of amines on the transfection efficiency of cationic peptidomimetic lipid molecules into neural cells.胺类阵列对阳离子拟肽脂质分子转染神经细胞效率的影响。
RSC Adv. 2022 Aug 3;12(33):21567-21573. doi: 10.1039/d2ra03347j. eCollection 2022 Jul 21.
10
Non-Pigmented Ciliary Epithelium-Derived Extracellular Vesicles Loaded with SMAD7 siRNA Attenuate Wnt Signaling in Trabecular Meshwork Cells In Vitro.负载SMAD7小干扰RNA的非色素睫状上皮衍生细胞外囊泡在体外减弱小梁网细胞中的Wnt信号传导
Pharmaceuticals (Basel). 2021 Aug 27;14(9):858. doi: 10.3390/ph14090858.
BRAF V600E 突变型黑色素瘤的获得性和内在 BRAF 抑制剂耐药性。
Biochem Pharmacol. 2011 Aug 1;82(3):201-9. doi: 10.1016/j.bcp.2011.05.015. Epub 2011 May 25.
4
Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.利用 CD4 适体-siRNA 嵌合体抑制人宫颈阴道外植体和人源化小鼠中的 HIV 传播。
J Clin Invest. 2011 Jun;121(6):2401-12. doi: 10.1172/JCI45876. Epub 2011 May 16.
5
A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.一种新型的肿瘤靶向递药系统,其由疏水性透明质酸-亚精胺缀合物(HHSCs)构成,可实现高效的受体介导的 siRNA 递药。
Int J Pharm. 2011 Jul 29;414(1-2):233-43. doi: 10.1016/j.ijpharm.2011.04.049. Epub 2011 Apr 23.
6
Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.通过受体介导的内吞作用实现 siRNA 和反义寡核苷酸的细胞递送。
Expert Opin Drug Deliv. 2011 Apr;8(4):435-49. doi: 10.1517/17425247.2011.561313. Epub 2011 Mar 8.
7
Pulmonary delivery of therapeutic siRNA.治疗性 siRNA 的肺部递释。
Adv Drug Deliv Rev. 2012 Jan;64(1):1-15. doi: 10.1016/j.addr.2011.02.006. Epub 2011 Feb 26.
8
Localized, targeted, and sustained siRNA delivery.局部、靶向和持续的 siRNA 递释。
Chemistry. 2011 Mar 7;17(11):3054-62. doi: 10.1002/chem.201003144. Epub 2011 Feb 21.
9
Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system.利用新型聚乙二醇化脂质体包埋海藻酸钠支架系统经阴道递送 siRNA。
J Control Release. 2011 Nov 7;155(3):418-26. doi: 10.1016/j.jconrel.2011.02.002. Epub 2011 Feb 18.
10
Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity.钙磷和聚乙二醇嵌段电荷转换聚合物负载的 siRNA 杂交纳米粒增强内涵体逃逸,实现高效基因沉默且细胞毒性可忽略。
Biomaterials. 2011 Apr;32(11):3106-14. doi: 10.1016/j.biomaterials.2010.12.057. Epub 2011 Jan 26.